Details.
Provides Edurant, Prezcobix, Prezista, and Symtuza for eligible patients. The uninsured program is operated by the Johnson & Johnson Patient Assistance Foundation, and the insured program is operated by Janssen Pharmaceuticals. Financial eligibility is 300% FPL.